SRPT Historical Earnings image   This SRPT historical earnings page last updated 11/4/2022
SRPT Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202211/2/20220.23B
Q2 20228/2/20220.23B
Q1 20225/4/20220.21B
Q4 20213/1/20220.20B
Q3 202111/3/20210.19B
Q2 20218/4/20210.16B
Q1 20215/5/20210.15B
Q4 20203/1/20210.15B
Q3 202011/5/20200.14B
Q2 20208/5/20200.14B
Q1 20205/6/20200.11B
Q4 20192/26/20200.10B
Q3 201911/7/20190.10B
Q2 20198/7/20190.09B
Q1 20195/8/20190.09B
Q4 20182/27/201984.42M
Q3 201810/24/201878.49M
Q2 20188/8/201873.53M
Q1 20185/3/201864.60M
Q4 20173/1/201857.28M
Q3 201710/25/201745.95M
Q2 20177/19/201735.01M
Q1 20174/27/201716.34M
Q4 20162/28/20175.42M
Q3 201610/27/2016NA
Q2 20167/19/2016NA
Q1 20165/5/2016NA
Q4 20152/25/20161.25M
Q3 201511/5/2015NA
Q2 20158/6/2015NA
Q1 20155/7/2015NA
Q4 20142/26/201527000
Q3 201411/6/20141.10M
Q2 20148/7/20142.60M
Q1 20145/8/20146.09M
Q4 20132/27/20142.60M
Q3 201311/12/20134.17M
Q2 20138/8/20133.00M
Q1 20135/9/20134.50M
Q4 20123/7/20137.30M
Q3 201211/7/20120.01B
Q2 20128/7/201211.20M
SRPT Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q3 202211/2/2022-0.800
Q2 20228/2/2022-1.180
Q1 20225/4/2022-0.560
Q4 20213/1/2022-0.770
Q3 202111/3/2021-0.190
Q2 20218/4/2021-1.520
Q1 20215/5/2021-1.540
Q4 20203/1/2021-1.840
Q3 202011/5/2020-1.420
Q2 20208/5/2020-1.510
Q1 20205/6/2020-1.040
Q4 20192/26/2020-1.570
Q3 201911/7/2019-1.140
Q2 20198/7/2019-0.830
Q1 20195/8/2019-0.750
Q4 20182/27/2019-0.85
Q3 201810/24/2018-0.56
Q2 20188/8/2018-0.43
Q1 20185/3/2018-0.28
Q4 20173/1/2018-0.28
Q3 201710/25/2017-0.2
Q2 20177/19/2017-0.46
Q1 20174/27/2017-0.6
Q4 20162/28/2017-0.71
Q3 201610/27/2016-0.95
Q2 20167/19/2016-1.19
Q1 20165/5/2016-1.15
Q4 20152/25/2016-1.3
Q3 201511/5/2015-1.11
Q2 20158/6/2015-0.87
Q1 20155/7/2015-1.15
Q4 20142/26/2015-0.94
Q3 201411/6/2014-0.7
Q2 20148/7/2014-0.61
Q1 20145/8/2014-0.55
Q4 20132/27/2014-0.77
Q3 201311/12/2013-0.63
Q2 20138/8/2013-0.46
Q1 20135/9/2013-0.41
Q4 20123/7/2013-2.36
Q3 201211/7/2012-2.170
Q2 20128/7/20120.36
Quotes delayed 20 minutes

Email EnvelopeFree SRPT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Sarepta Therapeutics (SRPT) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

SRRA Historical Earnings
SRRK Historical Earnings
SRTS Historical Earnings
SSKN Historical Earnings
STAA Historical Earnings
STAB Historical Earnings
STE Historical Earnings
STIM Historical Earnings
STOK Historical Earnings
STRO Historical Earnings
What was the record high SRPT historical earnings result?
In terms of earnings or revenue, what is the best SRPT historical earnings result that Sarepta Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest SRPT historical earnings result was set in Q2 2012, when Sarepta Therapeutics posted results of 0.36/share. The most successful revenue quarter within our data set was Q2 2022 when Sarepta Therapeutics reported revenue of 0.23B.

What was the lowest Sarepta Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest SRPT has reported, and when?

✔️Accepted answer: Within our data set, the lowest SRPT historical earnings result was set in Q4 2012, when Sarepta Therapeutics posted results of -2.36/share. The smallest revenue quarter within our data set was Q3 2016 when Sarepta Therapeutics reported revenue of NA.

On this page we presented the SRPT historical earnings date information for Sarepta Therapeutics. Reviewing that SRPT Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q2 2012, when SRPT posted adjusted EPS of 0.36/share. Meanwhile the lowest SRPT historical earnings result was in Q4 2012, when SRPT posted adjusted EPS of -2.36/share. Moving to Sarepta Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2022 when SRPT reported 0.23B in revenue, while the smallest revenue quarter was Q3 2016 when SRPT reported NA in revenue.

For self directed investors doing their due diligence on SRPT or any other given stock, their research can benefit from looking into all of the Sarepta Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Sarepta Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for SRPT. Thanks for visiting, and the next time you need to research SRPT historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: ZUMZ Split History, BCU Historical Stock Prices, Fox RSI.

 

SRPT Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.